8-K filed November 26, 2025, 6:59 PM ET ticker MTVA CIK 0001638287

regulatory confidence high sentiment neutral materiality 0.50

MetaVia receives Nasdaq extension to May 2026 to regain minimum bid price compliance

MetaVia Inc.

Company received Nasdaq approval for 180-day extension to May 26, 2026 to cure bid price deficiency.
Stock closed below $1.00 for 30+ days; compliance deadline originally Nov 25, 2025.
Stockholders previously approved reverse stock split at ratio between 1:5 and 1:30.
If not compliant by May 26, 2026, Nasdaq may delist; company may appeal.

item 3.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-116456
form_type: 8-K
ticker: MTVA
cik: 0001638287
company_name: MetaVia Inc.
filed_at: 2025-11-26T23:59:59+00:00
discovered_at: 2026-05-14T18:02:40.018350+00:00
generated_at: 2026-05-16T16:30:30.306051+00:00
sec_items: ["3.01"]
event_type: regulatory
sentiment: neutral
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-116456
json_url: https://secwatch.observer/filing/0001104659-25-116456.json
markdown_url: https://secwatch.observer/filing/0001104659-25-116456.md
text_url: https://secwatch.observer/filing/0001104659-25-116456.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/0001104659-25-116456-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1638287/000110465925116456/mtva-20251126x8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

04571c383834fdb15b8e7a81ce03da478feb6e01

MetaVia Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re

SEC 8-K Item 3.01 confidence 0.9 SEC evidence

612a5116dac2a1f76f303996f0d49516b549bd36

MetaVia Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

May 29, 2025, MetaVia Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) informing the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a period

SEC 8-K Item 3.01 confidence 0.9 SEC evidence

Comparable filings

CETY

Clean Energy Technologies receives Nasdaq delisting notice for late Q1 filing

Clean Energy Technologies, Inc. May 29, 2026, 4:57 PM ET regulatory Items 3.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: regulatory similar materiality

This filing

November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re

Comparable filing

May 26, 2026, Clean Energy Technologies, Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”) because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “ Quarterly Report ”). The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice has no immediate effect on the listing

Filing page SEC filing

FTHM

Fathom Holdings receives Nasdaq notice for late Q1 2026 10-Q filing; 60 days to submit plan

Fathom Holdings Inc. May 29, 2026, 4:15 PM ET regulatory Items 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: regulatory similar materiality

This filing

November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re

Comparable filing

May 22, 2026, Fathom Holdings Inc. (the “Company”) received a notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission (the “Filing Requirement”). In accordance with Nasdaq’s listing rules, the Company has 60 calendar days from the date of the notification letter

Filing page SEC filing

LASE

Laser Photonics receives Nasdaq delisting notice for late Q1 2026 10-Q

Laser Photonics Corp May 22, 2026, 5:27 PM ET regulatory Items 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: regulatory similar materiality

This filing

November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re

Comparable filing

received a notice from Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that since it had not received the Company’s Form 10-Q for the period ended March 31, 2026, the Company does not comply with Nasdaq’s Listing Rules for continued listing. Nasdaq stated that the Company has 60 days to submit a plan to regain compliance with respect to this delinquent report. Nasdaq can grant an exception to allow the Company to regain compliance up to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or November 16, 2026. A copy of t

Filing page SEC filing

RICK

RCI receives Nasdaq noncompliance notice for late Q2 10-Q; deadline July 20

RCI HOSPITALITY HOLDINGS, INC. May 22, 2026, 4:23 PM ET regulatory Items 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: regulatory similar materiality

This filing

November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re

Comparable filing

May 20, 2026, RCI Hospitality Holdings, Inc. (“we,” “us” and the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that we are

Filing page SEC filing

AVXL

Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026

ANAVEX LIFE SCIENCES CORP. May 22, 2026, 8:15 AM ET regulatory Items 3.01, 8.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: regulatory similar materiality

This filing

November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re

Comparable filing

May 20, 2026, Anavex Life Sciences Corp. (the “Company”) received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as

Filing page SEC filing

GTBP

GT Biopharma receives Nasdaq extension to Nov 16, 2026 to meet $1 minimum bid price

GT Biopharma, Inc. May 22, 2026, 8:00 AM ET regulatory Items 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: regulatory similar materiality

This filing

November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re

Comparable filing

May 20, 2026, GT Biopharma, Inc., a Delaware corporation (the “Company”), received a letter from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that

Filing page SEC filing

MYPS

PLAYSTUDIOS receives Nasdaq Capital Market transfer; second compliance period to Nov 2, 2026

PLAYSTUDIOS, Inc. May 5, 2026, 7:59 PM ET regulatory Items 3.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: regulatory similar materiality

This filing

November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re

Comparable filing

May 5, 2026, Nasdaq staff approved the Company’s application to transfer its listing to the Nasdaq Capital Market. The transfer will become effective at the opening of business on May 6, 2026 (the “Transfer Date”) and wi

Filing page SEC filing

HOTH

Hoth Therapeutics receives Nasdaq deficiency notice for minimum bid price non-compliance

Hoth Therapeutics, Inc. May 4, 2026, 7:59 PM ET regulatory Items 3.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: regulatory similar materiality

This filing

November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. If the Company does not re

Comparable filing

April 30, 2026, Hoth Therapeutics, Inc. (the “Company”) was notified (the “Notification Letter”) by The Nasdaq Stock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth i

Filing page SEC filing

Source: SEC EDGAR

accession 0001104659-25-116456

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.